The global demand for comprehensive testing solutions has undergone a seismic shift in the last decade. As we move towards the era of "Industry 4.0" and "Healthcare 5.0," the integration of molecular diagnostics with high-precision industrial testing is no longer a luxury but a fundamental necessity. In 2024, the market for diagnostic systems is projected to grow at a CAGR of 7.5%, driven by the decentralization of clinical laboratories and the surge in personalized medicine.
Modern laboratories are transitioning from manual assays to fully automated platforms like the Fluorescence Quantitative PCR Systems. This convergence allows for real-time data analysis and unprecedented accuracy in pathogen detection.
From 3D Dynamic AI Foot Care to automated imaging, Artificial Intelligence is now the core engine driving predictive analysis and reducing human error in clinical settings.
Enterprises worldwide are seeking "Single-Source" suppliers who can provide end-to-end solutions, spanning from ultra-pure biochemical reagents like N, N-Bis (2-hydroxyethyl) -2-Aminoethanesulphonic Acid to complete hardware platforms.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Why choose China for comprehensive testing solutions? The answer lies in Supply Chain Vertical Integration. Shenzhen BioX Medical leverages the world’s most robust electronics and biotech ecosystem, allowing for a rapid prototype-to-production cycle that is 40% faster than the global average.
Our product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Utilizing high-precision robotic assembly and ISO-certified cleanrooms to produce components like Air Bearing Transporters and Medical Laparoscopic Units.
We provide flexible OEM and ODM services for distributors and diagnostic companies seeking customized molecular testing solutions tailored to local regulatory requirements.
From individual CRP Test Kits to mass-scale Solar Power Systems for off-grid clinics, our capacity handles high-volume global procurement effortlessly.
Our solutions serve diverse sectors across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa:
BioX Medical
